The Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes

Authors

N. Ohri
S. Jolly
B. Cooper
R. Kabarriti
W. R. Bodner III
C. Guha
S. Viswanathan
E. Shum
J. K. Sabari
H. Cheng
R. Gucalp
E. Castellucci
A. Qin
Shirish M. Gadgeel, Henry Ford HealthFollow
B. Halmos

Recommended Citation

Ohri N, Jolly S, Cooper B, Kabarriti R, Bodner WR, Guha C, Viswanathan S, Shum E, Sabari JK, Cheng H, Gucalp R, Castellucci E, Qin A, Gadgeel SM, Halmos B. The Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys 2024; 120(2):S59.

Document Type

Conference Proceeding

Publication Date

10-1-2024

Publication Title

Int J Radiat Oncol Biol Phys

Volume

120

Issue

2

First Page

S59